 1. Clinical stage 2-3 rectal adenocarcinoma, cT34N0M0 or Tx N1-2M0, within 5 cm of anal verge or less than 12cm from anal verge and threatened circumferential resection margin 3mm. Patients must have histological confirmation of rectal adenocarcinoma prior to registration. 